Botulinum Toxin: Botox Injection May Have Antidepressant Effects.

A study applying safety surveillance data of botulinum toxin found significant connections between its use and antidepressant effects, across several suggestions and different injection sites, due to to the study's creators.

Their results show that the antidepressant impact of botulinum toxin "administered to different indications goes beyond the control of the proposed disease states and does not depend on the location of the injection, "according to Tigran Makunts, PhamaD, of the Skaggs School of Pharmacy and pharmaceutical sciences at the University of California, San Diego, coauthor.

Previous High-quality studies have discovered botulinum toxin treatment has been compared with antidepressant effects if administered to the glabellar region of the surface, they regarded.

For those who received botulinum toxin injection in facial muscles for cosmetic uses, the recording odds rate was 0.46, 95% confidence interval, 0.27-0.78. Significant consequences were also seen in the following groups: those who received injections into facial and head muscles for migraine, injections into the upper and lower limbs for spasms and spasticity. Injections into neck tissues for torticollis and neck pain, injections into eyelid muscles for blepharospasm and injections into the palm and axilla for hyperhidrosis.